Prologue: Deep Insights of Chemical Structures by Chemoinformatics Tools, Let’s Think Forward! by Stefaniu, Amalia
Selection of our books indexed in the Book Citation Index 
in Web of Science™ Core Collection (BKCI)
Interested in publishing with us? 
Contact book.department@intechopen.com
Numbers displayed above are based on latest data collected. 
For more information visit www.intechopen.com
Open access books available
Countries delivered to Contributors from top 500 universities
International  authors and editors
Our authors are among the
most cited scientists
Downloads
We are IntechOpen,
the world’s leading publisher of
Open Access books
Built by scientists, for scientists
12.2%
125,000 140M
TOP 1%154
5,000
1Chapter
Prologue: Deep Insights 
of Chemical Structures by 
Chemoinformatics Tools, Let’s  
Think Forward!
Amalia Stefaniu
1. Introduction - Multidisciplinary context
The constant need of chemical scientists to understand complex phenomena 
and process and to achieve a rational structural design by controlling the synthesis 
to obtain compounds with improved properties or materials with enhanced quality, 
together with advances in information technology, has led to development of a new 
branch of chemistry—chemoinformatics—with strong implications in life sciences 
such as molecular biology or biochemistry, with major interest in medicine, phar-
maceutical and food science industries.
Mainly, these interdisciplinary efforts are focused on the medical and pharmaceu-
tical area, aiming to improve the quality and standard of life, and have applications 
in drug design and development of new therapeutic strategies. Chemoinformatics, 
as new discipline, covers a broad spectrum of aspects including all applications of 
information technology to chemistry involving: constructing and archiving big 
compound libraries (small molecules and proteins) containing structural properties 
and molecular descriptors, spectra, X-ray crystallography data and so on; informa-
tion processing; large-scale chemical data mining; computational tools for structure 
and interactions visualisation, computational models for predicting interactions, 
to calculate properties and bioactivity, molecular docking and dynamic simulations 
methodologies, virtual screening, pharmacophore modelling, fragments similarity 
analysis, estimation of ADME (absorption, distribution, metabolism and excretion) 
characteristics, toxicity alerting, etc. [1–4]. The integration of chemical information 
and its transformation involves mathematical models and statistical data analysis.
Due to web servers and open data initiatives, large amount of chemical data from 
screening libraries are now available [5] and facilitate the drug discovery process. 
There are numerous chemoinformatics databases which contain various experimen-
tal and/or predicted properties of small molecules (ligands), peptides, proteins and 
data about their interactions (drug-drug interactions, ligand-protein interactions, 
protein-protein interactions, RNA-ligand interactions), chemical toxicity, bioactiv-
ity, adverse drug reactions, drug pathways, toxicogenomics, secondary metabolites, 
pharmacokinetics, etc. The existing data could help to build new structures and 
new models and to make new in silico predictions about physico-chemical proper-
ties and behaviour.
To raise awareness of the outstanding importance and impact of chemoinfor-
matics research, exemplified below are some of its applications in life sciences, 
preponderant in medicinal chemistry.
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2. Applications of chemoinformatics in medicinal chemistry
Novel druggable protein targets are a subject of research in order to develop new 
therapeutic strategies against various diseases (scleroderma, Alzheimer’s disease, 
infections, etc.). Investigations include methods such as quantitative structure-
activity relationships (QSAR), similarity search, pharmacophore modelling, 
molecular docking and dynamic simulations and toxicity assessment.
2.1 Anticancer therapy design
To fight against malignancies, new screening methods aim to identify and 
develop novel chemical antiproliferative agents, with promising results. As 
example, biomolecular modelling techniques are used to identify potential kinase 
inhibitor targets. The mitogen-activated protein kinase (MAPK) plays a key role in 
tumorigenesis; that is why it is considered a priority druggable target candidate for 
anticancer therapy. The interactions of cancer-related MAPK kinases and potential 
inhibitors are investigated by in silico tools. Molecular docking calculations are 
employed to predict the inhibitor-bound active sites and the binding modes for 
actual and potential anticancer drugs [6].
2.2 Parkinson’s disease
Researchers’ efforts to improve medication for Parkinson’s disease benefit from 
chemoinformatics and molecular docking tools to identify new potential neuropro-
tective compounds able to effectively treat the disease, by inhibition of oligomeriza-
tion process of α-synuclein protein. By computational techniques, the protein in 
its dimer and oligomer forms can be studied, and multiple molecules are subject of 
computational simulations in order to identify potential inhibitors of α-synuclein 
aggregation [7].
2.3 Alzheimer’s disease
Chemoinformatics approaches including molecular docking, dynamic simula-
tions, lead optimization and quantum chemical characterisation are used to achieve 
the inhibition of acetylcholinesterase (AChE) and butyrylcholinesterase (BChE) 
enzymes, responsible for cholinergic dysfunctions associated with the cognitive 
and behavioural abnormalities in dementing illness, in order to design and develop 
new therapeutic agents against this disease [8–11]. Other approaches focus on 
the amyloid-beta aggregation process, trying to stop the formation of neurotoxic 
species, and the design of new inhibitors, the study being also facilitated by compu-
tational techniques such as QSAR modelling and assessment of inhibition efficiency 
by predicting stability and binding modes of potential inhibitors through combined 
computational techniques including structure-activity relationships analysis, dock-
ing and molecular dynamic simulations [12–15].
2.4 Antimicrobial agents
Researchers focus their studies to block the activity of DNA gyrase and topoi-
somerase IV, which are essential bacterial enzymes involved in replication and 
recombination processes. The design of novel antibacterial agents that act against 
these enzymes can be realised by molecular docking techniques and bioactivity 
evaluation. That is the case of quinolones, which act equally against DNA gyrase 
and topoisomerase IV [16–19].
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Pharmacokinetics/ADMET properties such as absorption, distribution, metabo-
lism, excretion and toxicity of designed structures are assessed through computational 
approaches too, aiming to predict the therapeutic potential of the lead compound. 
Biochemical properties and drug-likeness according Lipinski’s rule of five (RO5) [20] 
and the molecular flexibility, as key descriptors to describe the oral bioavailability 
of drugs, are also predicted using computational tools. Thus, computer-aided drug 
design, coupled with in silico ADMET studies, helps to select the drug candidate 
molecules with possible better efficacy and less side effects (poor hepatotoxic effects).
3.  Application in identification and quantification of substances  
of abuse
Recent researches report the application of chemometric tools in correlation with 
spectrometric techniques (near-infrared spectroscopy) for onsite analysis of can-
nabinoids or amphetamine compounds (with portable and handheld NIR devices). 
The chemometric tools allow the user to compare collection of spectra, to develop 
prediction models and to achieve a real-time detection of sample contamination. Such 
method could become an alternative way of detection of illicit drugs, determined in 
oral fluids, being non-invasive, rapid and accurate test, completely automated [21, 22].
4. Applications in food chemistry
Food chemical data sets can be manipulated and analysed also by computational 
resources similar with those for drugs and nutraceuticals. The interest in this area 
is growing because of the food-related industrial challenges. Thus, an emerging 
field of research has arisen: foodinformatics [23]. In silico quantitative approaches 
are used to assess genotoxicity and carcinogenicity of food additives (flavours, 
colourants, contaminants, etc.) or cosmetic ingredients [24–26], in the attempts of 
safety evaluation for the human health. All these computational approaches must 
be verified by in vitro methods.
This section is a collection of advanced studies focusing on topics of interest in 
the context of chemoinformatics applications in drug discovery and design of new 
molecules.
© 2020 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
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